N-Boc-3-Bromopyrrolidine, 98.0%, 10g

6-Bromo-4-fluoro-2,3-dihydro-1H-inden-1-one, 95.0%, 10g

2,4-Dichloro-1-(prop-2-yn-1-yloxy)benzene, 95+%, 250mg

2-Bromo-5,6,7,8-tetrahydroimidazo[1,2-a]pyridine, 95+%, 50mg

Methyl 4-bromo-1H-indole-6-carboxylate, 95.0%, 25g

Colonne capillaire GC ROTI®Cap-1, 30 m, 0,25 mm, 0,50 µm, 1 pièce(s)

1-(2,3-dihydro-1,4-benzodioxin-2-yl)-N-methylethanamine, 95.0%, 10g

2-(3-Bromobenzoyl)oxazole, 97.0%, 1g

Objectif E-Plan phase EPLPH 20x/0,40. Distance de travail 1,85 mm

1-Piperidin-3-yl-ethylamine, 98%, 1g

4,7-Dibromo-2-phenylbenzo[d]thiazole, 95.0%, 1g

Saponin250g

Biphényle D10, 99 at%D, 1 g, emballage verre